Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa.
primary studies published RCT
Details- 2011
- Wainwright CE
Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
primary studies published RCT
Details- 2011
- Wainwright CE
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
primary studies published RCT
Details- 2010
- Accurso FJ
Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
primary studies published RCT
Details- 2010
- Amin R
Hyaluronic acid improves "pleasantness" and tolerability of nebulized hypertonic saline in a cohort of patients with cystic fibrosis.
primary studies published RCT
Details- 2010
- Buonpensiero P
Absorptive clearance of DTPA as an aerosol-based biomarker in the cystic fibrosis airway.
primary studies published RCT
Details- 2010
- Corcoran TE
Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis.
primary studies published RCT
Details- 2010
- Daviskas E
Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis--a randomized, double-blind placebo-controlled study.
primary studies published RCT
Details- 2010
- de Castro-Silva C
Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
primary studies published RCT
Details- 2010
- Graff GR
Evaluation of a home telemonitoring service for adult patients with cystic fibrosis: a pilot study.
primary studies published RCT
Details- 2010
- Grzincich G